Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial.
Fiche publication
Date publication
septembre 2018
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Ferreira JP, Barros A, Pitt B, Montalescot G, de Sa EL, Hamm CW, Flather M, Verheugt F, Shi H, Leite-Moreira A, Vincent J, Rossignol P, Zannad F
Lien Pubmed
Mots clés
Biomarkers, metabolism, Collagen, metabolism, Eplerenone, pharmacology, Fibrosis, prevention & control, Humans, Mineralocorticoid Receptor Antagonists, pharmacology, Randomized Controlled Trials as Topic, ST Elevation Myocardial Infarction, drug therapy
Référence
Clin Res Cardiol. 2018 Sep 27;: